Cargando…
Detection and Characterization of the Effect of AB‐FUBINACA and Its Metabolites in a Rat Model
Synthetic cannabinoids were originally developed by academic and pharmaceutical laboratories with the hope of providing therapeutic relief from the pain of inflammatory and degenerative diseases. However, recreational drug enthusiasts have flushed the market with new strains of these potent drugs th...
Autores principales: | Hsin‐Hung Chen, Michael, Dip, Aybike, Ahmed, Mostafa, Tan, Michael L., Walterscheid, Jeffrey P., Sun, Hua, Teng, Ba‐Bie, Mozayani, Ashraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063098/ https://www.ncbi.nlm.nih.gov/pubmed/26517302 http://dx.doi.org/10.1002/jcb.25421 |
Ejemplares similares
-
The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice
por: Trexler, Kristen R., et al.
Publicado: (2020) -
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
por: Lobato-Freitas, Carolina, et al.
Publicado: (2021) -
In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid
por: Carlier, Jeremy, et al.
Publicado: (2017) -
Characterisation of AMB-FUBINACA metabolism and CB(1)-mediated activity of its acid metabolite
por: Webb, Hunter D. J., et al.
Publicado: (2022) -
In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters
por: Kim, Sunjoo, et al.
Publicado: (2020)